Evidence map›Paper›PMID 24236095›Full record

ArticlePloS one2013

Targeted RNA-sequencing with competitive multiplex-PCR amplicon libraries.

Thomas M Blomquist, Erin L Crawford, Jennie L Lovett, Jiyoun Yeo, Lauren M Stanoszek, Albert Levin, Jia Li, Mei Lu, Leming Shi, Kenneth Muldrew and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Thomas M BlomquistDepartment of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Erin L Crawford
Jennie L Lovett
Jiyoun Yeo
Lauren M Stanoszek
Albert Levin
Jia Li
Mei Lu
Leming Shi
Kenneth Muldrew
James C Willey
University of Toledo · USHenry Ford Health System · USMichigan United · USUnited States Food and Drug Administration · US

Funding

Inherited genetic risk factors common to COPD and lung cancer.R01HL108016 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WILLEY, JAMES C. · 2011 to 2014
$1.9M
Implementation of innovative RNA sample quality control methodsR21CA138397 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WILLEY, JAMES C. · 2010 to 2011
$385k
NCI NIH HHS R21 CA138397NCI NIH HHS R21-CA138397NCI NIH HHS RC2-CA147652NHLBI NIH HHS R01 HL108016NHLBI NIH HHS R01-HL108016
6 · The paper itself

Abstract

Whole transcriptome RNA-sequencing is a powerful tool, but is costly and yields complex data sets that limit its utility in molecular diagnostic testing. A targeted quantitative RNA-sequencing method that is reproducible and reduces the number of sequencing reads required to measure transcripts over the full range of expression would be better suited to diagnostic testing. Toward this goal, we developed a competitive multiplex PCR-based amplicon sequencing library preparation method that a) targets only the sequences of interest and b) controls for inter-target variation in PCR amplification during library preparation by measuring each transcript native template relative to a known number of synthetic competitive template internal standard copies. To determine the utility of this method, we intentionally selected PCR conditions that would cause transcript amplification products (amplicons) to converge toward equimolar concentrations (normalization) during library preparation. We then tested whether this approach would enable accurate and reproducible quantification of each transcript across multiple library preparations, and at the same time reduce (through normalization) total sequencing reads required for quantification of transcript targets across a large range of expression. We demonstrate excellent reproducibility (R² = 0.997) with 97% accuracy to detect 2-fold change using External RNA Controls Consortium (ERCC) reference materials; high inter-day, inter-site and inter-library concordance (R² = 0.97-0.99) using FDA Sequencing Quality Control (SEQC) reference materials; and cross-platform concordance with both TaqMan qPCR (R²  = 0.96) and whole transcriptome RNA-sequencing following "traditional" library preparation using Illumina NGS kits (R² = 0.94). Using this method, sequencing reads required to accurately quantify more than 100 targeted transcripts expressed over a 10⁷-fold range was reduced more than 10,000-fold, from 2.3×10⁹ to 1.4×10⁵ sequencing reads. These studies demonstrate that the competitive multiplex-PCR amplicon library preparation method presented here provides the quality control, reproducibility, and reduced sequencing reads necessary for development and implementation of targeted quantitative RNA-sequencing biomarkers in molecular diagnostic testing.

Indexed as

Multiplex Polymerase Chain ReactionGene Expression ProfilingGene LibraryHigh-Throughput Nucleotide SequencingHumansReproducibility of ResultsReverse Transcriptase Polymerase Chain ReactionROC CurveSequence Analysis, RNATranscriptome

Identifiers

PMID24236095
PMCPMC3827295
OpenAlexW2060226894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.